Has Thomas Kepczyk, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,002,839 in general payments to Thomas Kepczyk, MD across 857 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Thomas Kepczyk, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Thomas Kepczyk, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Thomas Kepczyk, MD

Gastroenterology · San Marcos, TXNPI 1629062344

Payments from drug & device makers

$1,002,839in general payments, 2019–2025

Across 857 payments — averaging $1170.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Intercept Pharmaceuticals, Inc.$695K
Pfizer$101K
Madrigal Pharmaceuticals$87K
Intercept Pharma Europe Ltd.$54K
Genentech, Inc.$38K
Bausch Health US, LLC$17K
plus $12K from 41 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Intercept Pharmaceuticals, Inc.	138	$695,118
Pfizer(2 entities)	50	$100,607
Madrigal Pharmaceuticals	21	$87,389
Intercept Pharma Europe Ltd.	4	$54,054
Genentech, Inc.	6	$37,535
Bausch Health US, LLC	2	$16,500
AbbVie	198	$3,697
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	110	$1,395
Johnson & Johnson(2 entities)	50	$910
QOL Medical, LLC	34	$694
Takeda Pharmaceuticals U.S.A., Inc.	25	$447
Ferring Pharmaceuticals Inc.	28	$380
Gilead	20	$366
Lilly USA, LLC	12	$293
Regeneron Healthcare Solutions, Inc.	10	$266
Phathom Pharmaceuticals, Inc.	13	$237
Janssen Scientific Affairs, LLC	2	$235
Nestle Healthcare Nutrition Inc.	12	$227
Bristol Myers Squibb	14	$227
Echosens North America, Inc.	2	$223
Sanofi	7	$197
Daiichi Sankyo Inc.	10	$192
UCB, Inc.	8	$177
Ardelyx, Inc.	8	$164
Ipsen Biopharmaceuticals, Inc	6	$136
Merck	7	$129
Fujifilm Healthcare Americas Corporation	1	$125
Ironwood Pharmaceuticals, Inc	7	$121
Aimmune Therapeutics, Inc.	5	$100
Amgen	6	$96
Evoke Pharma, Inc.	6	$91
Redhill Biopharma Inc.	5	$84
Braintree Laboratories, Inc.	4	$63
Romark Laboratories, LC	5	$55
Celltrion USA Inc.	2	$49
AMAG Pharmaceuticals, Inc.	3	$48
Organon	2	$37
Fresenius Kabi USA, LLC	1	$32
Pharmacosmos Therapeutics Inc.	2	$31
Orphalan Inc	1	$22
Novo Nordisk	1	$20
Shire North American Group Inc	1	$19
Azurity Pharmaceuticals, Inc.	1	$17
Vivus LLC	1	$15
Alfasigma USA, Inc.	1	$13
Micro-tech Endoscopy USA, Inc.	1	$7
Gastrogpo, LLC	4	$0

How this compares

$1,002,839 in reported general payments places this provider in the 95th percentile of 1,350 gastroenterology providers in Texas.

See all gastroenterology providers in Texas →

Medicare billing

Part B allowed, 2024

$331,547

Medicare patients

781

Services billed

8,891

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other gastroenterology in San Marcos

Shannon MarekSan Marcos$616K
Eric LawitzSan Antonio$59.5M
George DuvallTyler$17.5M
John FordtranDallas$9.9M
Timothy RitterSouthlake$7.7M
Parvez MantryDallas$6.4M
Mazen NoureddinHouston$6.1M
Nadege GunnWaco$5.7M
Michael BrownDallas$5.5M
James MaherHouston$5.3M

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →